Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,184.50p
   
  • Change Today:
    -17.50p
  • 52 Week High: 1,989.00p
  • 52 Week Low: 855.60p
  • Currency: UK Pounds
  • Shares Issued: 240.87m
  • Volume: 297,863
  • Market Cap: 2,853.07m
  • RiskGrade: 246

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 1,365.00 298.00 139.10¢ 12.2 0.1 +126% 20.00¢ 1.2%
31-Dec-14 1,489.00 362.00 151.00¢ 18.5 2.1 +9% 22.00¢ 0.8%
31-Dec-15 1,440.00 318.00 143.70¢ 22.6 n/a -5% 32.00¢ 1.0%
31-Dec-16 1,950.00 210.00 118.50¢ 22.5 n/a -18% 33.00¢ 1.2%
31-Dec-17 1,936.00 (738.00) 105.00¢ 15.2 n/a -11% 34.00¢ 2.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 1,380.66 187.26 66.12p 17.9 n/a -10% 22.65p 1.9%
31-Dec-19 1,408.25 210.89 74.13p 16.0 1.3 +12% 23.43p 2.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 14.29 14.29 18.52 0.86

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

HIK Market Data

Currency UK Pounds
Share Price 1,184.50p
Change Today -17.50p
% Change -1.46 %
52 Week High 1,989.00p
52 Week Low 855.60p
Volume 297,863
Shares Issued 240.87m
Market Cap 2,853.07m
RiskGrade 246

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.1% below the market average17.1% below the market average17.1% below the market average17.1% below the market average17.1% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
51.12% below the market average51.12% below the market average51.12% below the market average51.12% below the market average51.12% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average
Income
44.67% below the market average44.67% below the market average44.67% below the market average44.67% below the market average44.67% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
75.64% below the market average75.64% below the market average75.64% below the market average75.64% below the market average75.64% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 7
Sell 1
Strong Sell 2
Total 14
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 05-Apr-18 24-Aug-17
Paid 24-May-18 22-Sep-17
Amount 23.00¢ 11.00¢

Trades for 19-Apr-2018

Time Volume / Share Price
16:53 804 @ 1,190.72p
16:53 200 @ 1,192.75p
16:53 204 @ 1,195.50p
16:53 318 @ 1,191.35p
16:52 200 @ 1,200.25p

HIK Key Personnel

CFO Khalid Nabilsi
CEO Sigurdur Olafsson

Top of Page